MedDataX Logo

A Randomized Controlled Trial of a Video Decision Aid in the ICU

NCT ID: NCT01776333

Last Updated: 2020-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Randomized Controlled Trial of a Video Decision Aid in the ICU in surrogates of admitted patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Failure Cardiac Event

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

ICU

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

usual care

Group Type NO_INTERVENTION

No interventions assigned to this group

video arm

video decision aid intervention

Group Type EXPERIMENTAL

video decision aid

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

video decision aid

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Age 65 or older Patient does not have the capacity to make decisions Patient admitted to the ICU with life threatening illness including advanced heart, renal, lung, gastrointestinal and oncologic disease Patient has English speaking representative to make decisions on his/her behalf Patient critically ill and unlikely to survive to hospital discharge

Exclusion Criteria

\- Patients who are imminently dying and admitted to the ICU are excluded Wards if the state
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Massachusetts General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Angelo E. Volandes, MD

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Angelo Volandes

Role: PRINCIPAL_INVESTIGATOR

MGH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cedars Sinai Medical Center

Los Angeles, California, United States

Site Status

BMC

Boston, Massachusetts, United States

Site Status

MGH

Boston, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Angelo Volandes

Role: CONTACT

Phone: 617 726 2000

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jonas Green

Role: primary

Michael Paasche-Orlow

Role: primary

Angelo Volandes

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2010-P-001820

Identifier Type: OTHER

Identifier Source: secondary_id

2010-P-001820

Identifier Type: -

Identifier Source: org_study_id